S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 97.5 TWD -0.51% Market Closed
Market Cap: 11.7B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Additional Paid In Capital
NT$2.2B
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
10%
Y
YungShin Global Holding Corp
TWSE:3705
Additional Paid In Capital
NT$2.3B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
1%
Formosa Laboratories Inc
TWSE:4746
Additional Paid In Capital
NT$3.6B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
9%
ScinoPharm Taiwan Ltd
TWSE:1789
Additional Paid In Capital
NT$1.3B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Additional Paid In Capital
NT$7.1B
CAGR 3-Years
-4%
CAGR 5-Years
2%
CAGR 10-Years
14%
Standard Chem & Pharm Co Ltd
TWSE:1720
Additional Paid In Capital
NT$298.9m
CAGR 3-Years
14%
CAGR 5-Years
9%
CAGR 10-Years
-3%
No Stocks Found

SCI Pharmtech Inc
Glance View

Market Cap
11.7B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
47.61 TWD
Overvaluation 51%
Intrinsic Value
Price
S

See Also

What is SCI Pharmtech Inc's Additional Paid In Capital?
Additional Paid In Capital
2.2B TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Additional Paid In Capital amounts to 2.2B TWD.

What is SCI Pharmtech Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
10%

Over the last year, the Additional Paid In Capital growth was 65%. The average annual Additional Paid In Capital growth rates for SCI Pharmtech Inc have been 18% over the past three years , 11% over the past five years , and 10% over the past ten years .

Back to Top